
Tirzepatide
CAS 2023788-19-2
$39.99 / vial
Synthetic 39-residue dual GIPR/GLP-1R agonist with a C20 fatty-diacid side chain on lysine 20.
Certificate of Analysis
Certificate of analysis available on request. [email protected]
Every product is third-party tested by an independent laboratory, and each certificate states the lot that was tested. Include your order number and the product name.
About this compound
Tirzepatide
Tirzepatide is a synthetic 39-amino-acid peptide that binds both the glucose-dependent insulinotropic polypeptide receptor (GIPR) and the glucagon-like peptide-1 receptor (GLP-1R).
The sequence contains α-aminoisobutyric acid at positions 2 and 13 and ends in a C-terminal amide. The lysine at position 20 is acylated on its side chain with 1,20-eicosanedioic acid through a γ-glutamate and two 2-[2-(2-aminoethoxy)ethoxy]acetyl spacers, which is what gives the molecule its long plasma half-life in the literature.
It is used in receptor pharmacology, competitive-binding and cAMP-signaling research on incretin receptors.
Supplied for laboratory research use only. Not intended for human or animal administration.
Specifications
| CAS number | 2023788-19-2 |
|---|---|
| Molecular formula | C225H348N48O68 |
| Molecular weight | 4813.53 g/mol |
| Sequence | Y-[Aib]-EGTFTSDYSI-[Aib]-LDKIAQK(C20 diacid-γGlu-AEEA-AEEA)AFVQWLIAGGPSSGAPPPS-NH2 |
| Appearance | White to off-white lyophilized powder |
| Form | Lyophilized powder |
| Sizes | 10mg CENV-TIRZ-10 |
Storage and handling
Store the sealed vial at −20 °C. Protect from light and moisture. Keep sealed until use.
Handling information covers the sealed vial only. These products are for laboratory research and are not for human or animal use.




